Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Orasi Medical General Information
Orasi Medical developed the Orasi Index™, a proprietary software platform leveraging magnetoencephalography (MEG) to provide non-invasive, reproducible biomarkers for neurological diseases. The technology was used by pharmaceutical companies to accelerate CNS drug development by measuring pharmacodynamics and treatment effects in real time. The company reported positive results from clinical trials in Alzheimer's disease and multiple sclerosis before ceasing operations.
Contact Information
Primary Industry
Physiological Monitoring
Corporate Office
Saint Louis Park / Edina / Minneapolis area, Minnesota
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Novartis Pharmaceuticals Corporation, H. Lundbeck A/S
Orasi Medical Funding
No funding data available
To view Orasi Medical's complete valuation and funding history, request access »